I have a question, one this Orlando fake guy asked

I have a question, one this Orlando fake guy asked, if Altucell under the high promise and early indication based on data really cures type one diabetes do you think the real value to generex is to commercialize it costing billions before Making revenues or selling it for billions and getting a 20 percent royalty a year for the life of the treatment? I guess the same question could go for Regentys and the merck trial.

Revenues are nice and they are
Only for getting to the bigger stuff and certainly not going to the equity markets every month, it’s a self funding initiative but in no way the holy grail. This goes
For Any company in pharma like ours, not gnbt specific.

Now I must go!